Episode Details
Back to Episodes
OCPs/HRT in BRCA Carriers: What’s the Evidence?
Published 6 years, 7 months ago
Description
Because of the increased risk for breast cancer, BRCA mutation carriers may have concerns about taking oral contraceptives or using hormone replacement therapy after a premenopausal prophylactic bilateral salpingo-oophorectomy (removal of the ovaries and fallopian tubes). Here, we review the current literature about hormone use by BRCA mutation carriers.